Quantcast Acelity - EWMA 2018

EWMA 2018

Krakow, Poland 9 - 11 May, 2018
 

Go Beyond Managing DFUs

Learn about the new clinical evidence demonstrating improved patient outcomes
in the management of DFUs with innovative solutions.

Diabetic Foot Ulcers

Are a major issue globally, with considerable economic and human cost. About 8.5% (422 million) of the world’s adult population has diabetes1 and of these up to 25% will develop a DFU2,3. ‘Compromised’ patients are at greater risk of developing a DFU3.

 
DFUs are associated with increased morbidity and mortality, with half of patients dying within 5 years4,5. DFUs are also expensive to treat. The costs associated with diabetes in the US and in Europe respectively are increasing by approximately US$9-13bn and up to €10bn per year6,7.
 
At KCI™ we take DFUs seriously. Our portfolio of Advanced Wound Dressings and Negative Pressure Wound Therapy is designed to offer you the right solution at the right stage of healing process.
 
 

Symposium 

Go Beyond: 
A Multi-disciplinary approach for the management of DFUs
When Thursday 10th May 16.00-17.00,
Where Room: Wisla Hall
 

Program Summary

Come and learn about the new clinical evidence demonstrating improved patient outcomes in the management of DFU’s with innovative solutions.
 
To find out more about the KCI portfolio for DFUs visit us at stand #W410
 
Symposium Speakers
Chair: Dr Maciej Zieliński, Poland
Welcome and Introduction highlighting the challenges of DFUs and the need for pathway solutions for DFU management. 
 
Speaker: Professor Luca Dalla Paola, Italy
The increasing role of surgery in diabetic foot treatment.
 
Speaker: Professor José Luis Lázaro Martínez, Spain
An Integral approach to Diabetic Foot Infections: Steps from the disaster to the total healing.
 

EWMA Meet The Experts

 
Wednesday 9th May
The Role of Collagen/ORC on Inflammation
and DFU
Presenter Prof. Lázaro Martínez, Spain
Time 12pm
 
The Mechanics of dNPWT
Presenter Dr Kieswetter, USA
Time 3.10pm
 
Thursday 10th
The Mechanics of dNPWT
Presenter Dr Kieswetter, USA
Time 9.40am
 
Role of NPWT in DFU treatment
Presenter Prof Banasiewicz, Poland
Time 12.30pm
 
Wound Cleansing with V.A.C. VERAFLO CLEANSE CHOICE™ Dressing
Presenter Dr Kim, USA
Time 12.55pm
 
The Role of Collagen/ORC on Inflammation
and DFU
Presenter Prof. Lázaro Martínez, Spain
Time 3.35pm
 
 
Friday 11th
Wound Cleansing with V.A.C. VERAFLO CLEANSE CHOICE™ Dressing
Presenter Dr Kim, USA
Time 10am
 
 

Products Designed to Help Diabetic Foot Ulcers

PROMOGRAN PRISMA™ Wound Balancing Matrix
PROMOGRAN PRISMA™ Matrix is comprised of a sterile, freeze dried composite of 44% oxidized regenerated cellulose (ORC), 55% collagen an 1% silver-ORC. Silver-ORC contains 25% w/w ionically bound silver, a well-known antimicrobial agent.PROMOGRAN PRISMA™ Matrix is indicated for the management of all wounds healing by secondary intent which are clear of necrotc tissue including: Diabetc ulcers, Venous ulcers, Pressure ulcers, Ulcers caused by mixed vascular aetiologies, Traumatic wounds and surgical wounds.
More Information on PROMOGRAN PRISMA™ Matrix:
 
 
SNAP™ Therapy System
Treat Wounds with the Power of a Disposable, Mechanically Powered NPWT System. The SNAP™ Therapy System is indicated for patients who would benefit from wound management via the application of negative pressure, particularly as the device may promote wound healing through the removal of small amounts of excess exudate, infectious material, and tissue debris.
More Information on SNAP™ Therapy System:
 
Specific indications, contraindications, warnings, precautions and safety information may exist for Systagenix and KCI (Acelity companies) products. Please consult a healthcare provider and product instructions for use prior to application.